Description

Enoxaparin Sodium

Drug Class: Low molecular weight heparins

• Safe & effective as subcutaneous unfractionated heparin (UFH) in the prevention of thromboembolic events caused by acute ischemic stroke. 

• Significantly more effective than a continuous infusion of unfractionated heparin in reducing the composite triple endpoint of death, MI, or recurrent angina or urgent revascularization.

• Highly effective for the treatment of acute coronary syndromes. 

• Has greater bioavailability with longer half-life & higher effectiveness, thus provides a moreanticoagulant response than UFH.